Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.440
-0.040 (-2.70%)
At close: Apr 28, 2026, 4:00 PM EDT
1.425
-0.015 (-1.07%)
Pre-market: Apr 29, 2026, 8:12 AM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $54.17 million as of April 29, 2026. Its market cap has increased by 5.01% in one year.
Market Cap
54.17M
Enterprise Value
-65.97M
1-Year Change
5.01%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $54.17M, a decrease of -90.38%. That is a compound annual growth rate of -65.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 55.68M | -8.46% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 61.81M |
| Cingulate | 61.17M |
| Cue Biopharma | 58.37M |
| MindWalk Holdings | 57.61M |
| Instil Bio | 55.14M |
| MiNK Therapeutics | 55.02M |
| Kezar Life Sciences | 53.86M |
| Entera Bio | 53.62M |